Solara Active Pharma Sciences Limited (SOLARA) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.39x

Solara Active Pharma Sciences Limited (SOLARA) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting Rs286.00 Million (capex Rs286.00 Million ) from operating cash flow of Rs740.70 Million. Check Solara Active Pharma Sciences Limited (SOLARA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.39x
(Capex + Investments) / Operating CF

Total Reinvested

Rs286.00 Million
Capex + Investments

Operating Cash Flow

Rs740.70 Million
INR

Capital Expenditures

Rs286.00 Million
INR

Solara Active Pharma Sciences Limited Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for Solara Active Pharma Sciences Limited across 8 annual periods. Explore Solara Active Pharma Sciences Limited long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Solara Active Pharma Sciences Limited (2017–2025)

Year-by-year capital reinvestment analysis for Solara Active Pharma Sciences Limited. For live market cap and broader valuation context, see SOLARA stock market capitalisation.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2025 0.36x Rs767.70 Million Rs2.13 Billion Rs399.40 Million ▼ -11.9%
2024 0.41x Rs445.70 Million Rs1.09 Billion Rs410.60 Million ▼ -66.8%
2023 1.23x Rs1.92 Billion Rs1.56 Billion Rs1.11 Billion ▲ +9.7%
2021 1.12x Rs1.75 Billion Rs1.55 Billion Rs1.74 Billion ▲ +2.0%
2020 1.10x Rs2.69 Billion Rs2.44 Billion Rs2.69 Billion ▲ +232.5%
2019 0.33x Rs529.43 Million Rs1.60 Billion Rs525.43 Million ▼ -53.6%
2018 0.71x Rs351.36 Million Rs492.23 Million Rs347.36 Million ▲ +0.0%
2017 0.71x Rs351.36 Million Rs492.23 Million Rs347.36 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow